06/08/2026 Biogen completed the acquisition of RayThera to strengthen its immunology pipeline Ono Pharmaceutical entered into a drug discovery partnership with Mediar Therapeutics to create novel antibody therapeutics for fibro-inflammatory diseases Biogen completed the acquisition of RayThera to strengthen its immunology pipeline (Ref) Biogen announced the completion of its acquisition of RayThera a biotechnology company focused on discovering and developing small-molecule t